Environmental Analysis of Therapeutic hMSC Manufacturing: A Comparison of Multiple Bioprocess Systems June 08, 2021 Biomanufacturing, Bioprocessing, Quality & Regulatory
Identify & Define Your Cell Therapy’s Biomanufacturing Approach for Critical Process… April 27, 2021 Biomanufacturing, Quality & Regulatory
Critical Quality Attributes (CQAs): Know Their Importance & Limitations in Product & Process… April 27, 2021 Biomanufacturing, Quality & Regulatory
“Known Unknowns” Affect Critical Process Parameters & Critical Quality Attributes in the… April 22, 2021 Biomanufacturing, Quality & Regulatory
Building Effective Multi-Year Process Development Programs II: Evolution of Technology Platform Decisions… March 30, 2021 BioEconomy, Biomanufacturing, Bioprocessing, Cell Therapy
Building Effective Multi-Year Process Development Programs I: Estimating hMSC Lot Size Ranges for… March 16, 2021 BioEconomy, Biomanufacturing, Bioprocessing, Cell Therapy
ISEV2020 Summary – Part II September 04, 2020 Biomanufacturing, Conference Highlights, Exosomes / Extracellular Vesicles
ISEV2020 Summary – Part I September 04, 2020 Biomanufacturing, Conference Highlights, Exosomes / Extracellular Vesicles
Final Product Containers for Cell Therapies August 21, 2020 Biomanufacturing, Bioprocessing, Cell Therapy
